We are live on ! Find out more
LAB icon

Standard BioTools
LAB

86 hedge funds and large institutions have $116M invested in Standard BioTools in 2023 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,900% more call options, than puts

Call options by funds: $30K | Put options by funds: $1K

167% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 9

59% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 17

19% more funds holding

Funds holding: 72 → 86 (+14)

5.56% more ownership

Funds ownership: 60.06% → 65.62% (+5.6%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

16% less capital invested

Capital invested by funds: $138M → $116M (-$21.4M)

Holders
86
Holders Change
+14
Holders Change %
+19.44%
% of All Funds
1.25%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
27
Reduced
17
Closed
9
Calls
$30K
Puts
$1K
Net Calls
+$29K
Net Calls Change
+$45K

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$7.27M
2
Millennium Management
Millennium Management
New York
+$2.24M
3
Renaissance Technologies
Renaissance Technologies
New York
+$910K
4
LCM
Laurion Capital Management
New York
+$640K
5
Jane Street
Jane Street
New York
+$598K

Top Sellers

1
EI
EAM Investors
California
-$1.37M
2
CP
Caligan Partners
New York
-$1.24M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$1.1M
4
BFM
Boothbay Fund Management
New York
-$850K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$419K
Name Holding Trade Value Shares
Change 		Change in
Stake
SSA
26
Schonfeld Strategic Advisors
New York
$423K +$103K +48,284 +34%
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$392K +$173K +81,015 +84%
Barclays
28
Barclays
United Kingdom
$361K +$246K +115,198 +239%
Two Sigma Investments
29
Two Sigma Investments
New York
$346K +$334K +156,603 New
HI
30
HBK Investments
Texas
$333K +$322K +150,781 New
JP Morgan Chase
31
JP Morgan Chase
New York
$319K +$305K +143,065 +10,913%
Goldman Sachs
32
Goldman Sachs
New York
$295K +$285K +133,560 New
Rockefeller Capital Management
33
Rockefeller Capital Management
New York
$289K -$2.4K -1,125 -0.9%
SAM
34
Silverback Asset Management
North Carolina
$276K -$374K -175,000 -58%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$243K +$26.5K +12,420 +13%
6CM
36
683 Capital Management
New York
$193K +$186K +87,189 New
Bank of America
37
Bank of America
North Carolina
$180K +$152K +71,128 +682%
ECM
38
ExodusPoint Capital Management
New York
$159K +$154K +72,025 New
Citadel Advisors
39
Citadel Advisors
Florida
$158K -$90.1K -42,206 -37%
Two Sigma Advisers
40
Two Sigma Advisers
New York
$158K +$110K +51,388 +258%
JF
41
Jump Financial
Illinois
$156K +$81.2K +38,030 +117%
Assenagon Asset Management
42
Assenagon Asset Management
Luxembourg
$145K +$140K +65,502 New
IP
43
Intellectus Partners
California
$139K – – –
PCH
44
Polar Capital Holdings
United Kingdom
$125K -$92.7K -43,415 -43%
JFG
45
Jefferies Financial Group
New York
$125K – – –
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$115K +$4.06K +1,904 +4%
BCPWM
47
Bradley & Co Private Wealth Management
Florida
$111K – – –
PCMI
48
Paradigm Capital Management Inc
New York
$111K +$107K +50,000 New
Commonwealth Equity Services
49
Commonwealth Equity Services
Massachusetts
$95K +$27.4K +12,832 +43%
YIH
50
Y-Intercept (HK)
Hong Kong
$87.3K +$84.3K +39,508 New
1
2
3 4

LAB Hedge Fund Activity: Q4 2023 in Review

86 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2023, worth a combined $116M — down 16% from $138M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new LAB positions and 9 closed out — a net gain of 15 holders — while 27 added to existing stakes and 17 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $7.27M. The largest seller was EAM Investors, exiting entirely with an estimated $1.37M sold.

  • 86 institutional investors held Standard BioTools (LAB) as of Q4 2023, up from 72 in Q3 2023.
  • Funds reported $116M of Standard BioTools stock for Q4 2023, down 16% quarter-over-quarter.
  • 24 funds opened new Standard BioTools positions in Q4 2023 and 9 closed out, a net change of +15 holders.
  • The largest Standard BioTools buyer in Q4 2023 was Morgan Stanley, an estimated $7.27M added.
  • The largest Standard BioTools seller in Q4 2023 was EAM Investors, an estimated $1.37M sold.

Based on aggregated 13F filings for Q4 2023.